News

The Salem News23h
FDA will allow 3 new color additives made from minerals, algae and flower petals
The FDA says it will allow three new color additives made from natural sources to be used in the nation’s food supply.
Interesting Engineering1d
Fluorescent drug gives surgeons visual upgrade with real-time nerve mapping
New fluorescent drug lights up nerve tissue under special imaging equipment, giving surgeons a visual edge during procedure.
A new drug causes nerve tissue to emit light, enabling faster, safer surgery
When surgeons dissect tissue to remove a tumor or make a repair, they must work cautiously, relying on electrophysical ...
MPR2d
FDA Approves Updated Label for Amyloid PET Imaging Agent Amyvid
The Food and Drug Administration (FDA) has approved an updated label for Amyvid (florbetapir F 18 injection) to support Alzheimer disease diagnosis in patients.
Zacks Investment Research on MSN2d
FDA Grants Accelerated Approval to Regeneron's Blood Cancer Drug
Regeneron Pharmaceuticals, Inc. REGN obtained FDA approval for linvoseltamab-gcpt for the treatment of relapsed or refractory ...
Ophthalmology Times2d
Lupin receives FDA approval for Loteprednol Etabonate Ophthalmic Gel, 0.38%
Lupin Limited secures FDA approval for Loteprednol Etabonate Ophthalmic Gel, enhancing treatment options for postoperative ...
Stocktwits on MSN3d
Regeneron’s Therapy For Blood Cancer Bags FDA Approval: REGN Stock Jumps
Regeneron Pharmaceuticals, Inc. (REGN) on Wednesday announced that the U.S. Food and Drug Administration has granted accelerated approval for its Lynozyfic to treat adult patients with relapsed or ...
US FDA approves Regeneron's blood cancer therapy
Regeneron Pharmaceuticals said on Wednesday the U.S. Food and Drug Administration has approved its drug for a type of blood ...
Regeneron Gets Accelerated FDA OK of Lynozyfic for Blood Cancer Treatment
Regeneron Pharmaceuticals has won FDA accelerated approval of its Lynozyfic treatment for certain patients with the blood cancer multiple myeloma.
Merck granted FDA priority review for Winrevair label update
Merck (MRK) stock in focus as its lung disease drug Winrevair gains FDA priority review for a label update based on Phase 3 ...
BioWorld3d
Regeneron wins FDA nod for BCMA bispecific Lynozyfic
It may be a year later than originally planned, but Regeneron Pharmaceuticals Inc. is set to commercialize Lynozyfic (linvoseltamab) in the U.S. following FDA approval for use in adults with relapsed ...